In Silico ADME/T Properties of Quinine Derivatives using SwissADME and pkCSM Webservers
Jean Gonfi M. Mvondo, Aristote Matondo, Dani T. Mawete, Sylvie-Mireille N. Bambi, Blaise M. Mbala, Pierre O. Lohohola
International Journal of TROPICAL DISEASE & Health · pp. 1–12 · Published 3 Aug 2021
10.9734/ijtdh/2021/v42i1130492Abstract
Aim: Malaria is among the most devastating and widespread tropical parasitic diseases. To overcome antimalarial drug resistance, new drugs need to be developed. This study is designed to establish the pharmacokinetic profile and toxicity of nine quinine derivatives as potential antimalarial drugs using in silico approaches by SwissADME and pkCSM. Methodology: The structures of investigated compounds were translated into canonical SMILES format and then submitted to SwissADME web tool that gives free access to physicochemical properties, pharmacokinetics, drug-likeness and medicinal chemistry friendliness of compounds, and pkCSM webserver for predicting and optimizing pharmacokinetic and toxicity properties. Results: SwissADME mainly used to predict the physicochemical properties of compounds and their drug-likeness revealed that all quinine derivatives have good bioavailability and satisfied the Lipinski’s rule of five. The pkCSM results on the absorption, distribution, metabolism, excretion and toxicity show that all investigated compounds have a good pharmacokinetic profile and they are safe since they belong to class 4 of the Globally Harmonized System (300 < Category 4 ≤ 2000 mg/kg/day). Conclusion: Drug-likeness and ADME/T predictions of nine investigated quinine derivatives revealed that they are good candidates to oral drug formulation and thus they can be used in a broader context of overcoming the development of resistance by Plasmodium protozoans against most of the drugs currently used to treat malaria. As future prospects, further studies on bioevaluation of compounds are needed to elucidate their potential pharmacological activities.
Cited by 80
Krishna Narayan Mishra, Mayank Rashmi, Harish Chandra Upadhyay · Indian Journal of Pharmaceutical Education and Research · 2024
Armin Gudarzi, Lotfollah Saghaei, Neda Fayyazi · Results in Chemistry · 2025
Kalyani R. Thombre, Krishna R. Gupta, Milind J. Umekar · Chemical Biology & Drug Design · 2026
Reehana Shaik, Ishwarya Obilineni, Naga Venkata Chenchu Lakshmi Kollipara · Biomedical & Pharmacology Journal · 2025
Noor Mousa, Abdull Jabar Attia, Karima Fadhil Ali · Al Mustansiriyah Journal of Pharmaceutical Sciences · 2025
Loveline N. Amen, Jude Y. Betow, Mathieu J.M. Tjegbe · Scientific African · 2025
Indah Purwaningsih, Iman Permana Maksum, Dadan Sumiarsa · Journal of Toxicology · 2025
Josiah Joseph Isah, Adamu Uzairu, Sani Uba · Network Modeling Analysis in Health Informatics and Bioinformatics · 2025
Leyla Ercan, Cemile Günbegi Çalişkan · Biocatalysis and Agricultural Biotechnology · 2026
Shanmugampillai Jeyarajaguru Kabilan, Oviya Sivakumar, Selvaraj Kunjiappan · Journal of Research in Pharmacy · 2025
Showing 20 of 80 known citations — external sources report more than can currently be individually listed.
Related research
- ABO Blood Groups and Malaria Prevalence in a Referral Hospital in Nigeria — shares topic coverage
- Prevalence of Malaria among Pregnant Women and Children Under Five Years in Abi Local Government Area, Cross River State, Nigeria — shares topic coverage
- A Study on Relationship of Thrombocytopenia and Likelihood of Severe Malaria in Patients Admitted With Malaria in a Tertiary Care Hospital of Dakshina Kannada — shares topic coverage
- Platelet Alteration in Plasmodium vivax Malaria Patients in Thailand — shares topic coverage
- Patients’ Perception of Health Care Services in Malaria Endemic Area in Mali: Villages with Health Care Services Versus villages Without Health Care Services — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
80
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.